Author | Adam M. Brufsky, MD | OncLive

Author | Adam M. Brufsky, MD


Dr. Brufsky on the Disease-Free Survival of Aromatase Inhibitors for Breast Cancer

July 15, 2017


Adam M. Brufsky, MD, PhD, professor of Medicine, associate chief of Hematology/Oncology, co-director of the Comprehensive Breast Care Center, associate director of Clinical Investigation, University of Pittsburgh, discusses the 5 versus 10 year disease-free survival of aromatase inhibitors investigated in the NSAPB B-42 trial.